RAMUNĖLĖS VAISTINĖ - Company finances
|
EUR
|
2018
From: 2017-09-01
To: 2018-08-31
|
2019
From: 2018-09-01
To: 2019-08-31
|
2020
From: 2019-09-01
To: 2020-08-31
|
2021
From: 2020-09-01
To: 2021-08-31
|
2022
From: 2021-09-01
To: 2022-09-30
|
2023
From: 2022-10-01
To: 2023-09-30
|
2024
From: 2023-10-01
To: 2024-09-30
|
2025
From: 2024-10-01
To: 2025-09-30
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 7,505,203 | 8,762,987 | 6,362,648 | 5,450,515 | 6,605,928 | 6,458,449 | 6,503,122 | 6,954,749 |
| Profit before tax | 28,091 | 57,000 | -46,644 | -261,998 | -92,656 | -137,670 | -437,469 | -209,487 |
| Net profit | 27,524 | 53,622 | -46,441 | -247,637 | -95,288 | -134,867 | -422,519 | -216,354 |
| Equity | -655,089 | -601,467 | -647,908 | -895,545 | -990,833 | 387,692 | -34,827 | -251,181 |
| Liabilities | 2,166,589 | 2,596,867 | 1,832,345 | 2,109,033 | 3,120,224 | 1,272,136 | 1,643,018 | - |
| Non-current assets | 122,508 | 111,056 | 94,880 | 108,812 | 110,255 | 104,780 | 115,734 | - |
| Current assets | 1,366,139 | 1,866,177 | 1,083,687 | 1,049,543 | 1,968,757 | 1,532,365 | 1,573,249 | - |
| Total assets | 1,488,647 | 1,977,233 | 1,178,567 | 1,158,355 | 2,079,012 | 1,637,145 | 1,688,983 | 0 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 273,537 | 269,313 | 336,919 |
| Social insurance contributions | - | - | - | - | - | 249,675 | 282,863 | 315,245 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -28.5% | +16.8% | -27.4% | -14.3% | +21.2% | -2.2% | +0.7% | +6.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 1.8% | 2.7% | -3.9% | -21.4% | -4.6% | -8.2% | -25.0% | - |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | -34.8% | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.4% | 0.6% | -0.7% | -4.5% | -1.4% | -2.1% | -6.5% | -3.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.4% | 0.7% | -0.7% | -4.8% | -1.4% | -2.1% | -6.7% | -3.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | 3.3 | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 120,727 | 142,875 | 110,495 | 93,571 | 116,919 | 124,201 | 129,846 | 138,403 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
RAMUNĖLĖS VAISTINĖ - Social security debts
The company had no debts to Sodra
RAMUNĖLĖS VAISTINĖ - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
RAMUNELES VAISTINE, UAB (Private Limited Liability Company, code 181528234) operates in retail sale of pharmaceutical products. In 2025, revenue increased to €6.95M from €6.50M in 2024 and €6.46M in 2023, indicating steady growth across the three-year period. Year-on-year revenue growth was 6.9% in 2025, and the two-year increase reached 7.7%. Profitability remained negative, however the loss narrowed in 2025: net loss was €216.4K, compared with €422.5K in 2024 and €134.9K in 2023. The profit margin improved to -3.1% in 2025 from -6.5% in 2024, although the company still operated below break-even. At year-end 2025, total assets stood at €1.54M, liabilities at €1.76M and equity at negative €251.2K. Asset turnover was 4.50x, showing that the asset base generated relatively high revenue. Revenue per employee reached €139.1K, while profit per employee remained negative at €4.3K.